In addition, TMZ-combined SMP treatment also significantly reduces tumor growth rates, decreases the area of tumor necrosis, and increases apoptosis compared to the other two treatment cohorts, i.e., the TMZ vehicle and TMZ-combined Gliadel treatment cohorts. The gene discussed is FAM53B; the disease is neoplasm.